fbpx
June 1, 2020

FDA approves atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

On May 29, 2020, the Food and Drug Administration approved atezolizumab in combination with bevacizumab (TECENTRIQ and AVASTIN, Genentech Inc.) for patients with unresectable or metastatic […]
June 1, 2020

Continuing Education Courses

Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes This continuing education (CE) course will educate a national audience […]
May 29, 2020

Coronavirus (COVID-19) Update: Daily Roundup May 29, 2020

For Immediate Release: May 29, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
May 29, 2020

Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic

Image By: Stephen M. Hahn, M.D., Commissioner of Food and Drugs In hospitals all across this country, doctors continue to deal with the influx of COVID-19 […]
May 29, 2020

Understanding the Regulatory Terminology of Potential Preventions and Treatments for COVID-19

Image There’s a lot of confusion about which medical products might work to prevent or treat coronavirus disease 2019 (COVID-19). Scientists are working hard to develop […]
May 29, 2020

COVID MyStudies Application (App)

The U.S. Food and Drug Administration is making its previously developed FDA MyStudies app available to investigators as a free platform to obtain informed consent securely […]
May 29, 2020

FDA’s MyStudies Application (App) Technical Background

The FDA MyStudies app lets patients provide data that can be linked to traditional clinical trials, real-world trials, observational studies, and registries. Open source code and […]
May 29, 2020

Pescatlantic Group, LLC – 496990 – 05/26/2020

Delivery Method: VIA Electronic Mail Reference #: 20-HAFE4-WLCOL-09 Product: Drugs Recipient: Recipient Name Mr. Cesar Calvo Recipient Title CEO Pescatlantic Group, LLC 6100 Blue Lagoon Dr.Suite […]
May 29, 2020

Shoreside Enterprises Inc. – 422722 – 05/26/2020

Delivery Method: VIA Electronic Mail Reference #: 20-HAFE4-WLCOL-07 Product: Drugs Recipient: Recipient Name Mr. Brian Moses Recipient Title President Shoreside Enterprises Inc. 6321 Newtown Cir.Apt B1Tampa, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0